11 May 2023
Ropes & Gray Represents Solarea Bio in Series B Financing to Support Launch of Two Medical Food Products
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brad Flint Lead | Ropes & Gray | Partner | venture capital & emerging companies | Not stated |
| Danielle Heinlein | Ropes & Gray | Associate | venture capital & emerging companies | Not stated |
| Joe Muller | Ropes & Gray | Associate | venture capital & emerging companies | Not stated |
Stated terms
- Stated value
- USD 15m ($15 million)
- What the figure measures
- Total transaction value
- Client
- Solarea BioIssuer
- Counterparties
- S2G Ventures (Investor)
Bold Capital Partners (Investor)
Viking Global Investors (Investor)
GG 1978 SICAF SIF (Investor)